gritt.io›Find investors›Therapeutics in United States

Top 2026 Therapeutics Early Stage Investors in United States

Discover the top 710 therapeutics early stage investors in United States based on their portfolio. Get their email and LinkedIn info.

710
Investors
557
With email
78%
Email rate
Nov 2026
Last updated

Investor search results

712 investors found
🌍 United States📊 early stage🏷 Therapeutics
Omri Amirav-Drory
Omri Amirav-Drory
General Partner at NFX
Early stage11 in Therapeutics28 investments 📍 United States
11
in Therapeutics
Caroline Farah Lembck, MBA, PhD (abd)
Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
Late stage11 in Therapeutics76 investments 📍 United States
11
in Therapeutics
Ayman A.
Ayman A.
Investing in venture and growth-stage companies transforming industries
Early stage10 in Therapeutics36 investments 📍 United States
10
in Therapeutics
Tim Walbert
Tim Walbert
Managing Partner, HRZN Partners LLC; Sr. Advisor, Amgen; Sr. Advisor, Patient Square Capital
Mid stage9 in Therapeutics18 investments 📍 United States
9
in Therapeutics
LI
Lucio Iannone
Investor at Leaps by Bayer
Early stage9 in Therapeutics21 investments 📍 United States
9
in Therapeutics
Paulina Hill
Paulina Hill
Partner and Head of Investments, Sanofi Ventures
Early stage8 in Therapeutics15 investments 📍 United States
8
in Therapeutics
Greg Yap
Greg Yap
Partner at Menlo Ventures
Early stage8 in Therapeutics23 investments 📍 United States
8
in Therapeutics
Eric Pham, PhD
Eric Pham, PhD
Managing Director, Avego
Mid stage7 in Therapeutics11 investments 📍 United States
7
in Therapeutics
Nessan Bermingham
Nessan Bermingham
Serial biotech entrepreneur & investor
Early stage7 in Therapeutics9 investments 📍 United States
7
in Therapeutics
Daniel Wagner
Daniel Wagner
Early-Stage Investor | Advisor for disruptive life science startups
Early stage7 in Therapeutics24 investments 📍 United States
7
in Therapeutics

Frequently asked questions about Therapeutics investors in United States

How many Therapeutics early-stage investors are there in United States?
Gritt tracks 710 Therapeutics early-stage investors in United States, of which 557 (78%) have a direct email address available.
How can I contact Therapeutics investors in United States?
Gritt provides direct email addresses for 78% of investors in this list. On a paid plan you can unlock them and export the list, or use Gritt AI outreach to draft personalised emails that you approve, or let Gritt approve, and send from your Gmail.
Are these investors actively investing in United States startups?
Gritt lists them most active first, by the number of deals they have made in Therapeutics, and each profile shows those deals and their dates. To see only investors who have invested recently, use the Last active filter.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Therapeutics investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.

Contact all 710 Therapeutics early-stage investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required